Follow The Filings

CLB Core Laboratories Inc.

Energy, filed as CORE LABORATORIES INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 1.6%
  • $164M
  • 1 add

In 2026 Q2 John Rogers added to Core Laboratories.

Who owns this now

Largest portfolio weights among holders, up to 1.6% (John Rogers, Ariel Investments). Not free-float ownership.

  1. John Rogers Add 1.6%

Who owns CLB

Sorted by value, long equity only, as of 2026 Q2.

History
John Rogers, Ariel Investments 1.6% Add +6.9% 14,074,945 $164M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CLB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CLB insider trades
  • $54K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Lawrence Bruno CEO
    Buy
    $54K 5,000 shares at $10.78 +1.9% to stake
    Traded Jul 31 Filed Aug 4
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 option exercises and 11 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K Filing Doc
8-K 7.01,9.01 Filing Doc
8-K/A 2.02 Filing Doc
8-K 5.03,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 12 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $509.79M $523.85M $526.52M
Gross profit * — $103.33M $108.93M
Gross margin * — 19.7% 20.7%
Net income $36.68M $31.4M $29.67M
Net margin * 7.2% 6.0% 5.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $223.14M $226.61M $214.66M
Total non-current assets * $363.26M $363.8M $369.34M
Total assets $586.4M $590.41M $584.01M
Total current liabilities $88.1M $97.59M $106.02M
Total equity $224.82M $251.99M $265.99M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $24.79M $56.39M $37.03M
Cash from investing -$6.65M -$6.39M -$2.23M
Cash from financing -$18.44M -$45.96M -$31.26M
Net change in cash * -$0.308M $4.04M $3.54M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.